Is Renalytix Stock a Good Investment?

Renalytix Investment Advice

RNLX

To provide specific investment advice or recommendations on Renalytix AI stock, we recommend investors consider the following general factors when evaluating Renalytix AI. This will help you to make an informed decision on whether to include Renalytix in one of your diversified portfolios:

Examine Renalytix's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Renalytix's leadership team and their track record. Good management can help Renalytix navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Technology space and any emerging trends that could impact Renalytix's business and its evolving consumer preferences.
Compare Renalytix's performance and market position to its competitors. Analyze how Renalytix is positioned in terms of product offerings, innovation, and market share.
Check if Renalytix pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Renalytix's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Renalytix AI stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Renalytix AI is a good investment.

Sell

Buy

Strong Sell

We provide trade recommendations to complement the recent expert consensus on Renalytix AI. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Renalytix is not overpriced, please check all Renalytix AI fundamentals, including its net income, as well as the relationship between the book value per share and market capitalization . As Renalytix AI appears to be a penny stock we also advise to check out its number of shares shorted numbers.

Market Performance	Very Weak	Details
Volatility	Out of control	Details
Hype Condition	Stale	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Very High	Details
Economic Sensitivity	Moves completely opposite to the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Strong Buy	Details
Reporting Quality (M-Score)	Unavailable	Details

Examine Renalytix Stock

Researching Renalytix's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 0.9. Renalytix AI had not issued any dividends in recent years.

To determine if Renalytix is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Renalytix's research are outlined below:

	Renalytix AI generated a negative expected return over the last 90 days
	Renalytix AI has high historical volatility and very poor performance
	Renalytix AI has some characteristics of a very speculative penny stock
	Renalytix AI has a very high chance of going through financial distress in the upcoming years
	The company reported the previous year's revenue of 3.4 M. Net Loss for the year was (46.22 M) with profit before overhead, payroll, taxes, and interest of 720 K.
	Renalytix AI currently holds about 32.36 M in cash with (32.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
	Latest headline from benzinga.com: Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15

Renalytix Quarterly Accounts Payable

2.82 Million

Renalytix uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Renalytix AI. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Renalytix's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	4th of April 2024 Upcoming Quarterly Report	View
	14th of June 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	26th of September 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	30th of June 2023 Last Financial Announcement	View

Earnings surprises can significantly impact Renalytix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Renalytix's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2021-12-07	2021-09-30	-0.12	-0.14	-0.02	16
2024-02-13	2023-12-31	-0.09	-0.18	-0.09	100
2021-06-15	2021-03-31	-0.145	-0.24	-0.095	65
2023-09-28	2023-06-30	-0.13	-0.24	-0.11	84
2023-11-15	2023-09-30	-0.1	-0.22	-0.12	120
2020-11-25	2020-09-30	-0.07	-0.2	-0.13	185
2023-03-30	2022-12-31	-0.14	-0.28	-0.14	100
2023-06-09	2023-03-31	-0.11	-0.28	-0.17	154

Know Renalytix's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Renalytix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Renalytix AI backward and forwards among themselves. Renalytix's institutional investor refers to the entity that pools money to purchase Renalytix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Ewa, Llc	2023-12-31	34.5 K
North Star Investment Management Corp	2023-12-31	31 K
Morgan Stanley - Brokerage Accounts	2023-12-31	29.7 K
Xtx Topco Ltd	2023-12-31	22 K
Wealth Enhancement Advisory Services, Llc	2023-12-31	19.6 K
Lpl Financial Corp	2023-12-31	18.5 K
Virtu Financial Llc	2023-12-31	14.7 K
Ironwood Investment Counsel, Llc	2023-12-31	12 K
White Bay Pt Llc	2023-12-31	1.8 K
Cvi Holdings Llc	2023-12-31	1.1 M
Gilder Gagnon Howe & Co Llc	2023-12-31	879.5 K

Note, although Renalytix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Renalytix's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 48.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Renalytix's market, we take the total number of its shares issued and multiply it by Renalytix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

97.51 Million

Renalytix's profitablity analysis

Renalytix's profitability indicators refer to fundamental financial ratios that showcase Renalytix's ability to generate income relative to its revenue or operating costs. If, let's say, Renalytix is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Renalytix's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Renalytix's profitability requires more research than a typical breakdown of Renalytix's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.

	Last Reported	Projected for Next Year
Return On Tangible Assets	(1.80)	(1.71)
Return On Capital Employed	(1.87)	(1.78)
Return On Assets	(1.26)	(1.20)
Return On Equity	(2.88)	(2.74)

Determining Renalytix's profitability involves analyzing its financial statements and using various financial metrics to determine if Renalytix is a good buy. For example, gross profit margin measures Renalytix's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Renalytix's profitability and make more informed investment decisions.

The data published in Renalytix's official financial statements usually reflect Renalytix's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Renalytix AI. For example, before you start analyzing numbers published by Renalytix accountants, it's critical to develop an understanding of what Renalytix's liquidity, profitability, and earnings quality are in the context of the Health Care Technology space in which it operates.

Please note, the presentation of Renalytix's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Renalytix's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Renalytix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Renalytix AI. Please utilize our Beneish M Score to check the likelihood of Renalytix's management manipulating its earnings.

Evaluate Renalytix's management efficiency

Renalytix AI has return on total asset (ROA) of (0.8832) % which means that it has lost $0.8832 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.514) %, meaning that it created substantial loss on money invested by shareholders. Renalytix's management efficiency ratios could be used to measure how well Renalytix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -1.71 in 2024. Return On Capital Employed is likely to rise to -1.78 in 2024. At this time, Renalytix's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 18 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 7.6 M in 2024.

	Last Reported	Projected for Next Year
Book Value Per Share	0.52	0.49
Net Current Asset Value	0.00	0.00
Tangible Asset Value	0.00	0.00
Tangible Book Value Per Share	0.40	0.72
Enterprise Value Over EBITDA	(2.73)	(2.86)
Price Book Value Ratio	7.48	9.12
Enterprise Value Multiple	(2.73)	(2.86)
Price Fair Value	7.48	9.12
Enterprise Value	69.7 M	66.2 M

The analysis of Renalytix's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Renalytix's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Renalytix Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Beta

1.978

Basic technical analysis of Renalytix Stock

As of the 10th of May, Renalytix holds the Risk Adjusted Performance of 0.0875, coefficient of variation of 793.8, and Semi Deviation of 9.19. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Renalytix, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Renalytix AI, which can be compared to its competitors. Please check Renalytix AI variance and potential upside to decide if Renalytix AI is priced some-what accurately, providing market reflects its current price of 0.62 per share. As Renalytix AI is a penny stock we also suggest to check out its total risk alpha numbers.

Renalytix's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Renalytix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Renalytix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Renalytix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Icahn School Of Medicine At Mount Sinai over two weeks ago Acquisition by Icahn School Of Medicine At Mount Sinai of 9360374 shares of Renalytix at 0.25 subject to Rule 16b-3
		Coste Catherine over three months ago Acquisition by Coste Catherine of 95000 shares of Renalytix subject to Rule 16b-3
		Mclain Thomas H over six months ago Acquisition by Mclain Thomas H of 200000 shares of Renalytix subject to Rule 16b-3

Understand Renalytix's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Renalytix's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0875
	Market Risk Adjusted Performance	(0.24)
	Mean Deviation	14.23
	Semi Deviation	9.19
	Downside Deviation	11.03
	Coefficient Of Variation	793.8
	Standard Deviation	32.6
	Variance	1062.95
	Information Ratio	0.1234
	Jensen Alpha	5.3
	Total Risk Alpha	0.2251
	Sortino Ratio	0.3648
	Treynor Ratio	(0.25)
	Maximum Drawdown	263.66
	Value At Risk	(14.18)
	Potential Upside	40.96
	Downside Variance	121.68
	Semi Variance	84.53
	Expected Short fall	(21.48)
	Skewness	5.5
	Kurtosis	36.07

	Risk Adjusted Performance	0.0875
	Market Risk Adjusted Performance	(0.24)
	Mean Deviation	14.23
	Semi Deviation	9.19
	Downside Deviation	11.03
	Coefficient Of Variation	793.8
	Standard Deviation	32.6
	Variance	1062.95
	Information Ratio	0.1234
	Jensen Alpha	5.3
	Total Risk Alpha	0.2251
	Sortino Ratio	0.3648
	Treynor Ratio	(0.25)
	Maximum Drawdown	263.66
	Value At Risk	(14.18)
	Potential Upside	40.96
	Downside Variance	121.68
	Semi Variance	84.53
	Expected Short fall	(21.48)
	Skewness	5.5
	Kurtosis	36.07

Consider Renalytix's intraday indicators

Renalytix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Renalytix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	7558.73
	Daily Balance Of Power	(0.50)
	Rate Of Daily Change	0.98
	Day Median Price	0.62
	Day Typical Price	0.62
	Price Action Indicator	(0.01)
	Period Momentum Indicator	(0.01)
	Relative Strength Index	40.76

Renalytix time-series forecasting models is one of many Renalytix's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Renalytix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Renalytix Stock media impact

Far too much social signal, news, headlines, and media speculation about Renalytix that are available to investors today. That information is available publicly through Renalytix media outlets and privately through word of mouth or via Renalytix internal channels. However, regardless of the origin, that massive amount of Renalytix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Renalytix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Renalytix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Renalytix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Renalytix alpha.

Renalytix Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Renalytix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Renalytix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital

All Next

Launch Module

Renalytix Corporate Management

Elected by the shareholders, the Renalytix's board of directors comprises two types of representatives: Renalytix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Renalytix. The board's role is to monitor Renalytix's management team and ensure that shareholders' interests are well served. Renalytix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Renalytix's outside directors are responsible for providing unbiased perspectives on the board's policies.

Oliver III	Chief Officer	Profile
Jean Casner	VP Officer	Profile
Baljit Singh	Head Operations	Profile
Howard Doran	Chief Officer	Profile
Salim FCA	Company Secretary	Profile
Fergus Fleming	Chief Officer	Profile
Andria ParksHerrera	VP Marketing	Profile

How to buy Renalytix Stock?

Examine Renalytix's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Renalytix's leadership team and their track record. Good management can help Renalytix navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Technology space and any emerging trends that could impact Renalytix's business and its evolving consumer preferences.
Compare Renalytix's performance and market position to its competitors. Analyze how Renalytix is positioned in terms of product offerings, innovation, and market share.
Check if Renalytix pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Renalytix's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

Already Invested in Renalytix AI?

The danger of trading Renalytix AI is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Renalytix is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Renalytix. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Renalytix AI is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

When determining whether Renalytix AI offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Renalytix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Renalytix Ai Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Renalytix Ai Stock: